ARTICLE | Clinical News
SC0806 regulatory update
October 11, 2010 7:00 AM UTC
The European Commission granted Orphan Drug designation for BioArctic's SC0806 to treat traumatic spinal cord injury (SCI). The heparin-activated recombinant human fibroblast growth factor 1 (FGF-1) ...